VivoSim Labs (VIVS) Net Income towards Common Stockholders (2010 - 2026)
VivoSim Labs (VIVS) recorded Net Income towards Common Stockholders of -$1.34 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$2.84 million a year earlier.
Powered by 
Analysis
VivoSim Labs (VIVS) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
On a TTM basis, VivoSim Labs' Net Income towards Common Stockholders came in at -$12.34 million as of Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it came in at -$13.84 million.
- Across earlier fiscal years, Net Income towards Common Stockholders came in at -$2.49 million in FY2025, -$14.67 million in FY2024, -$17.26 million in FY2023 and -$11.45 million in FY2022.
- The fiscal Q1 2027 figure is the highest quarterly Net Income towards Common Stockholders since fiscal Q4 2025.
- Per Business Quant, the preceding three fiscal quarters came in at -$5.76 million (Q4 2026), -$2.69 million (Q3 2026) and -$2.55 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.45 Bn | 36.15 Bn | 1.44 Bn | 256.00 Mn |
| 2 | Medpace Holdings | 17.53 Bn | 15.59 Bn | 201.64 Mn | 121.36 Mn |
| 3 | Charles River Laboratories International | 15.19 Bn | 14.39 Bn | 363.37 Mn | -1.48 Mn |
| 4 | Icon | 13.68 Bn | 10.79 Bn | 479.29 Mn | 72.58 Mn |
| 5 | Fortrea Holdings | 2.17 Bn | 1.54 Bn | 139.20 Mn | -13.20 Mn |
| 6 | Ginkgo Bioworks Holdings | 614.73 Mn | -147.35 Mn | 18.44 Mn | -46.71 Mn |
| 7 | Evotec SE | 529.18 Mn | -1.08 Bn | - | - |
| 8 | Champions Oncology | 66.43 Mn | 41.52 Mn | 7.70 Mn | -426,000.00 |
| 9 | MindWalk Holdings | 59.60 Mn | 23.25 Mn | 1.61 Mn | -4.37 Mn |
| 10 | VivoSim Labs | 905,903.01 | -16.82 Mn | - | -1.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.34 Mn |
| Mar 31, 2026 | -5.76 Mn |
| Dec 31, 2025 | -2.69 Mn |
| Sep 30, 2025 | -2.55 Mn |
| Jun 30, 2025 | -2.84 Mn |
| Mar 31, 2025 | 6.85 Mn |
| Dec 31, 2024 | -3.45 Mn |
| Sep 30, 2024 | -2.55 Mn |
| Jun 30, 2024 | -3.34 Mn |
| Mar 31, 2024 | -3.05 Mn |
| Dec 31, 2023 | -3.60 Mn |
| Sep 30, 2023 | -3.99 Mn |
| Jun 30, 2023 | -4.03 Mn |
| Mar 31, 2023 | -7.46 Mn |
| Dec 31, 2022 | -3.26 Mn |
| Sep 30, 2022 | -3.32 Mn |
| Jun 30, 2022 | -3.22 Mn |
| Mar 31, 2022 | -1.91 Mn |
| Dec 31, 2021 | -3.50 Mn |
| Sep 30, 2021 | -3.51 Mn |
API Access
VivoSim Labs Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=VIVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "VIVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=VIVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();